全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

Pneumonia as a Sign of Sickle Cell Disease: About a Case with Review of the Literature

DOI: 10.4236/oalib.1111637, PP. 1-6

Subject Areas: Infectious Diseases

Keywords: Pneumonia, Sickle Cell Disease, Child, Kinshasa University Clinic

Full-Text   Cite this paper   Add to My Lib

Abstract

Background: Pulmonary infections including pneumonia during sickle cell disease are common and fall within the definition of acute chest syndrome. This clinical syndrome is defined by the association of a recent thoracic radiological abnormality with a clinical manifestation: chest pain, fever, or dyspnea. Methods: This is an observational, descriptive study of a special case discovered during a pediatric consultation at the university clinics of Kinshasa. Its presentation being a case not yet found at the university clinics makes its publication valuable. Result: We report the observation of an 8-year-old patient with hand-foot-mouth syndrome and 2 previous pneumonias, without any notion of parental consanguinity. On his physical examination, he presented crackling rales at the base of the right lung, O2 desaturation at 88% in open air. The emergency assessment revealed a hemoglobin level of 8 g/dl, a leukocytosis of 18,000/mm3, a leukocyte formula: N83%L12% M5%E0%B0%; C Reactive Protein at 48 mg/l. The thick film was negative. The chest X-ray (Front) revealed right basal lung disease of presumably infectious origin. Conclusion: This work emphasizes the frequency of the occurrence of pneumonia and its potential seriousness in a little-known sickle cell patient.

Cite this paper

Ngonde, F. N. , Nkodila, A. N. , Bifu, C. , Kumbu, J. M. , Sekele, P. M. N. and Aketi, L. P. (2024). Pneumonia as a Sign of Sickle Cell Disease: About a Case with Review of the Literature. Open Access Library Journal, 11, e1637. doi: http://dx.doi.org/10.4236/oalib.1111637.

References

[1]  Pereira-Martins, D.A., Domingos, I.F., Belini-Junior, E., Coelho-Silva, J.L., Weinhäuser, I., Araújo, A.S., et al. (2021) Association of HMIP1 C-893A Polymorphism and Disease Severity in Patients with Sickle Cell Anemia. Hematology, Transfusion and Cell Therapy, 43, 243-248.
https://doi.org/10.1016/j.htct.2020.03.006
[2]  Rees, D.C., Brousse, V.A.M. and Brewin, J.N. (2022) Determinants of Severity in Sickle Cell Disease. Blood Reviews, 56, Article 100983.
https://doi.org/10.1016/j.blre.2022.100983
[3]  Wastnedge, E., Waters, D., Patel, S., Morrison, K., Goh, M.Y., Adeloye, D., et al. (2018) The Global Burden of Sickle Cell Disease in Children under Five Years of Age: A Systematic Review and Meta-Analysis. Journal of Global Health, 8, Article 021103. https://doi.org/10.7189/jogh.08.021103
[4]  Nardo-Marino, A., Brousse, V. and Rees, D. (2020) Emerging Therapies in Sickle Cell Disease. British Journal of Haematology, 190, 149-172.
https://doi.org/10.1111/bjh.16504
[5]  Williams, T.N. (2016) Sickle Cell Disease in Sub-Saharan Africa. Hematology/Oncology Clinics of North America, 30, 343-358.
https://doi.org/10.1016/j.hoc.2015.11.005
[6]  Frangoul, H., Altshuler, D., Cappellini, M.D., Chen, Y., Domm, J., Eustace, B.K., et al. (2021) Crispr-Cas9 Gene Editing for Sickle Cell Disease and Β-Thalassemia. New England Journal of Medicine, 384, 252-260. https://doi.org/10.1056/nejmoa2031054
[7]  Salim, A.S., Mwita, E., Antwi, J.S., Agunkejoye, O. and Mdliva, P. (2021) Living with Sickle Cell Disease: Voices from Sub-Saharan Africa. The Lancet Haematology, 8, e684-e685. https://doi.org/10.1016/s2352-3026(21)00276-3
[8]  Esoh, K., Wonkam-Tingang, E. and Wonkam, A. (2021) Sickle Cell Disease in Sub-Saharan Africa: Transferable Strategies for Prevention and Care. The Lancet Haematology, 8, e744-e755. https://doi.org/10.1016/s2352-3026(21)00191-5
[9]  Zhou, A.E. and Travassos, M.A. (2022) Bringing Sickle-Cell Treatments to Children in Sub-Saharan Africa. New England Journal of Medicine, 387, 488-491.
https://doi.org/10.1056/nejmp2201763
[10]  Mattioni, S., Stojanovic, K.S., Girot, R. and Lionnet, F. (2016) La drépanocytose en France. Revue Francophone des Laboratoires, 2016, 61-66.
https://doi.org/10.1016/s1773-035x(16)30129-0
[11]  Mukinayi, B.M., Cibeyibeyi, G.K., Tumba, G.D. and Gulbis, B. (2021) Drépanocytose en République Démocratique du Congo: Quels sont les obstacles à un traitement par hydroxyurée? Pan African Medical Journal, 38, Article 41.
https://doi.org/10.11604/pamj.2021.38.41.18718
[12]  Beytout, J., Tournilhac, O. and Laurichesse H. (2003) Asplenia and Hyposplenism. La Presse Médicale, 32, S5-S9.
[13]  Legrand, A., Bignon, A., Borel, M., Zerbib, P., Langlois, J., et al. (2005) Prévention du risque infectieux postopératoire chez les patients splénectomisés. Annales Françaises d’Anesthésie et de Réanimation, 24, 807-813.
https://doi.org/10.1016/j.annfar.2005.05.002
[14]  Tshilolo, L. (2006) Les complications habituelles de la drépanocytose chez l’enfant en Afrique. Développement et santé, 3, 101-103.
[15]  Vichinsky, E.P., Neumayr, L.D., Earles, A.N., Williams, R., Lennette, E.T., Dean, D., et al. (2000) Causes and Outcomes of the Acute Chest Syndrome in Sickle Cell Disease. New England Journal of Medicine, 342, 1855-1865.
https://doi.org/10.1056/nejm200006223422502
[16]  Knight-Madden, J.A. and Hambleton, I.R. (2003) Inhaled Bronchodilators for Acute Chest Syndrome in People with Sickle Cell Disease. Cochrane Database of Systematic Reviews, No. 9, CD003733.
[17]  Ohene-Frempong, K., Weiner, S.J., Sleeper, L.A., et al. (1998) Cerebrovascular Accidents in Sickle Cell Disease: Rates and Risk Factors. Blood, 91, 288-294.

Full-Text


Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133